Literature DB >> 20045053

Alterations of cortical and hippocampal EEG activity in MeCP2-deficient mice.

Jennifer Anne D'Cruz1, Chiping Wu, Tariq Zahid, Youssef El-Hayek, Liang Zhang, James H Eubanks.   

Abstract

Rett syndrome is a pediatric neurological condition caused by mutations of the gene encoding the transcriptional regulator MECP2. In this study, we examined cortical and hippocampal electroencephalographic (EEG) activity in male and female MeCP2-deficient mice at symptomatic stages during different behavioral states. During acute sleep, MeCP2-deficient mice displayed normal delta-like activity in cortex and sharp-wave activity in hippocampus. However, when the mice were awake but immobile, abnormal spontaneous, rhythmic EEG discharges of 6-9 Hz were readily detected in the somatosensory cortex. During exploratory activity, MeCP2-deficient mice displayed clear theta rhythm activity in hippocampus, but its peak frequency was significantly attenuated compared to wild type. Collectively, these findings indicate that a deficiency in MeCP2 function in mice leads to alterations in EEG activity with similarities to what has been observed clinically in Rett syndrome patients. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045053     DOI: 10.1016/j.nbd.2009.12.018

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  34 in total

1.  Selective impact of MeCP2 and associated histone deacetylases on the dynamics of evoked excitatory neurotransmission.

Authors:  Erika D Nelson; Manjot Bal; Ege T Kavalali; Lisa M Monteggia
Journal:  J Neurophysiol       Date:  2011-04-20       Impact factor: 2.714

2.  MeCP2: only 100% will do.

Authors:  Hsiao-Tuan Chao; Huda Y Zoghbi
Journal:  Nat Neurosci       Date:  2012-01-26       Impact factor: 24.884

3.  Regulation of seizure-induced MeCP2 Ser421 phosphorylation in the developing brain.

Authors:  Evan C Rosenberg; Jocelyn J Lippman-Bell; Marcus Handy; Samantha S Soldan; Sanjay Rakhade; Cristina Hilario-Gomez; Kaitlyn Folweiler; Leah Jacobs; Frances E Jensen
Journal:  Neurobiol Dis       Date:  2018-05-05       Impact factor: 5.996

Review 4.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

Review 5.  Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD).

Authors:  Galen Missig; Christopher J McDougle; William A Carlezon
Journal:  Neuropsychopharmacology       Date:  2019-05-06       Impact factor: 7.853

6.  The neural circuit basis of Rett syndrome.

Authors:  Darren Goffin; Zhaolan Joe Zhou
Journal:  Front Biol (Beijing)       Date:  2012-10

7.  Brain activity mapping in Mecp2 mutant mice reveals functional deficits in forebrain circuits, including key nodes in the default mode network, that are reversed with ketamine treatment.

Authors:  Miriam Kron; C James Howell; Ian T Adams; Michael Ransbottom; Diana Christian; Michael Ogier; David M Katz
Journal:  J Neurosci       Date:  2012-10-03       Impact factor: 6.167

8.  Loss of MeCP2 from forebrain excitatory neurons leads to cortical hyperexcitation and seizures.

Authors:  Wen Zhang; Matthew Peterson; Barbara Beyer; Wayne N Frankel; Zhong-wei Zhang
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

Review 9.  Age, plasticity, and homeostasis in childhood brain disorders.

Authors:  Maureen Dennis; Brenda J Spiegler; Jenifer J Juranek; Erin D Bigler; O Carter Snead; Jack M Fletcher
Journal:  Neurosci Biobehav Rev       Date:  2013-10-03       Impact factor: 8.989

10.  A Role for Diminished GABA Transporter Activity in the Cortical Discharge Phenotype of MeCP2-Deficient Mice.

Authors:  Liang Zhang; Robert G Wither; Min Lang; Chiping Wu; Elena Sidorova-Darmos; Hristo Netchev; Catherine B Matolcsy; Orlando Carter Snead; James H Eubanks
Journal:  Neuropsychopharmacology       Date:  2015-10-26       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.